SCHEMBL17632146

SCHEMBL17632146

Cc1ccc(-c2ccc(N(C#N)C(=O)C3CCNC3)nc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ USP30 Q70CQ3 3/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ KDM1A O60341 12/20 0.38
▸ KCNH2 Q12809 2/20 0.38
▸ RCOR1 Q9UKL0 1/20 0.38
▸ MAOB P27338 1/20 0.35
▸ AKT1 P31749 1/20 0.35
▸ CDK9 P50750 1/20 0.34
▸ TLR9 Q9NR96 2/20 0.34
▸ TLR8 Q9NR97 2/20 0.34
▸ TLR7 Q9NYK1 2/20 0.34
▸ GRIN2B Q13224 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17632787 0.91 MEN1 (0.40) USP30MEN1CYP2D6KMT2AKDM1A
SCHEMBL17631943 0.90 USP30 (0.49) USP30CDK9GRIN2B
SCHEMBL17632326 0.90 USP30 (0.49) USP30CDK9GRIN2B
SCHEMBL17631696 0.90 USP30 (0.41) USP30KDM1AKCNH2CDK9TLR9
SCHEMBL17631859 0.89 USP30 (0.39) USP30KDM1ATLR9TLR8TLR7
SCHEMBL17632423 0.86 CDK9 (0.40) USP30MEN1CYP2D6KMT2ACDK9
SCHEMBL17631958 0.85 MKNK1 (0.45) USP30KDM1AKCNH2
SCHEMBL17632076 0.83 USP30 (0.39) USP30KCNH2CDK9
SCHEMBL17631951 0.82 SLC6A2 (0.38) KCNH2
SCHEMBL17632002 0.81 CDK9 (0.41) KDM1ACDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP claimed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO claimed
EP-3197883-A1 NOVEL COMPOUNDS Mission Therapeutics Limited (GB) 2017-08-02 — — EP disclosed
WO-2016046530-A1 NOVEL COMPOUNDS MISSION THERAPEUTICS LTD (GB) 2016-03-31 — — WO disclosed
Send feedback